Clinical and microbiological characterization of pneumonia in mechanically ventilated patients

Brazilian Journal of Infectious Diseases

Volumn 16, Issue 5, 2012, Pages 442-447

  Medell, Manuel ^a   Hart, Marcia ^a   Marrero, Odalys ^a   Espinosa, Fidel ^a   Montes de Oca, Zurelys ^a   Valdés, Rodolfo ^b  

^a HOSPITAL CLINICOQUIRÚRGICO HERMANOS AMEIJEIRAS   (Cuba)

^b CENTER FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Cuba)

Author keywords

Antibacterial agents; Pneumonia; Respiratory care units

Indexed keywords

AMIKACIN; AMPICILLIN; AZTREONAM; CARBAPENEM; CEFEPIME; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; COLISTIN; GENTAMICIN; IMIPENEM; MEROPENEM; NALIDIXIC ACID; SULTAMICILLIN; TIGECYCLINE;

ACINETOBACTER BAUMANNII; ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL CELL WALL; BACTERIUM ISOLATE; CLINICAL PULMONARY INFECTION SCORE; CONTROLLED STUDY; ENTEROBACTER CLOACAE; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; HUMAN; IN VITRO STUDY; KLEBSIELLA PNEUMONIAE; LUNG INFILTRATE; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MOLECULAR PATHOLOGY; MORAXELLA; MORAXELLA LACUNATA; NUCLEIC ACID SYNTHESIS; OBSERVATIONAL STUDY; PATHOGENESIS; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; SCORING SYSTEM; STENOTROPHOMONAS MALTOPHILIA; TREATMENT DURATION; VANCOMYCIN RESISTANT ENTEROCOCCUS; VENTILATOR ASSOCIATED PNEUMONIA;

ANTI-BACTERIAL AGENTS; FEMALE; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; INTENSIVE CARE UNITS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PNEUMONIA, VENTILATOR-ASSOCIATED;

EID: 84866847066     PISSN: 14138670     EISSN: 16784391     Source Type: Journal    
DOI: 10.1016/j.bjid.2012.08.005     Document Type: Article

References (34)

1. Rello J. Ventilator-associated pneumonia. Electronic Review Intensive Medicine 2004, 4:1-22.
2. Gene L. Historical perspective on the development of mechanical ventilation. Principles & practice of mechanical ventilation 2006, McGraw-Hill, New York. 2nd ed. J. Martin, Tobin (Eds.).
3. Baxter A.D., Allan J., Bedard J., et al. Adherence to simple and effective measures reduces the incidence of ventilator-associated pneumonia. Can J Anesth 2005, 5:535-541.
4. Rello J., SaBorges M., Correa H., et al. Variations in ethiology of ventilator-associated pneumonia around four treatment sites: implications for antimicrobial prescribing practices. Am J Respir Care Med 1999, 160:608-613.
5. Gasink B., Fishman N., Nachamkin I., et al. Risk factors for and impact of infection or colonization with aztreonam-resistant Pseudomonas aeruginosa. Infect Control Hosp Epidemiol 2007, 28:1175-1180.
6. Aloush V., Navon-Venezia S., Seigman-Igra, et al. Multidrug-resistant Pseudomonas aeruginosa. Risk factors and clinical impact. Antimicrob Agents Chemother 2006, 50:43-48.
7. Parker C.M., Kutsogiannis J., Muscedere J., et al. Ventilator-associated pneumonia caused by multi-drug-resistant organisms or Pseudomonas aeruginosa: prevalence, incidence, risk factors, and outcomes. J Crit Care 2008, 23:18-26.
8. Noor A., Hussain F. Risk factors associated with development of ventilator associated pneumonia. J Coll Physicians Surg Pak 2005, 15:92-95.
9. Pujin J., Auckenthaler R., Mili N. Diagnosis of ventilator associated pneumonia by bacteriologic analysis of bronchoscopy blind bronchoalveolar lavage fluid. Clinical Pulmonary Infection Score, CPIS. Am Rev Respir Dis 1991, 142:1121-1129.
10. Performance standard for antimicrobial disc susceptibility test. Approved standard M2-A2S2 1981, National Committee for Clinical Laboratory Standards, National Committee for Clinical Laboratory Standards, Wayne, PA.
11. Vincent J.L., Bihari D.J., Suter P.M., Bruining H.A., White J. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC study). JAMA 1995, 274:639-644.
12. Carrillo R., Cruz C., Miguel C. Pneumonia associated with mechanical ventilation. Rev Asoc Mex Med Crit y Ter Int 2002, 16:90-96.
13. Chastre J., Fagon J.Y. Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002, 165:867-873.
14. Mercado R. Nosocomial Pneumonia. Neumología y Cirugía de Tórax 2005, 64:79-83.
15. Labaut N., Riera R., Pérez I., Castañeda Y. Pneumonia associated with mechanical ventilation in the intensive care unit. MEDISAN 2011, 15:1759.
16. Spencer R.C. Predominant pathogens found in the European prevalence of infection in intensive care study. Eur J Clin Microbiol Infect Dis 1996, 15:281-285.
17. Ortiz G., Fonseca N., Molina F., et al. Epidemiology of ventilator-associated pneumonia in 39 intensive care units of Colombia (2007-2009). 2010 report 2011, 11:12-19.
18. Ruiz M., Guerrero J., Romero C. Etiology of ventilator-associated pneumonia in a university hospital. Association with co-morbidity previous use of antibiotics and mortality. Rev Chil Infect 2007, 24:131-136.
19. Fica A., Cifuentes M., Hervé B. Update of the consensus document on ventilator-associated pneumonia. Part I. Diagnostic aspects. Rev Chil Infect 2011, 28:130-151.
20. González J., Lescay M., Machado R.A., et al. Nosocomial Pneumonia. Result of a year of work in the ICU of Hermanos Ameijeiras Hospital. Rev Cub Med Int Emerg 2002, 1:32-41. duas revistas?
21. Salazar E., Nieves B. Acinetobacter spp: Aspectos microbiológicos, clínicos y epidemiológicos. Rev Soc Ven Microbiol 2005, 2:29-32.
22. Garnacho-Montero J., Ortiz-Leyba C., Fernandez-Hinojosa E., et al. Acinetobacter baumannii ventilator-associated pneumonia: epidemiological and clinical findings. Intensive Care Med 2005, 31:649-655.
23. Agbaht K., Díaz E., Muñoz E., et al. Bacteremia in patients with ventilator-associated pneumonia is associated with increased mortality: a study comparing bacteremic vs non-bacteremic ventilator-associated pneumonia. Crit Care Med 2007, 35:2064-2070.
24. Kollef M., Afessa B., Anzueto A., et al. Silver-coated endotracheal tubes and incidence of ventilator-associated pneumonia: the NASCENT randomized trial. JAMA 2008, 300:805-813. NASCENT Investigation Group.
25. Vallésa J., Mariscal D. Neumonía por Pseudomonas aeruginosa. Enferm Infecc Microbiol Clin 2005, 23:30-36.
26. Niederman M., Mantovani R., Schock P., et al. Patterns and routes of tracheobronchial colonization in mechanically ventilated patients: the role of nutritional status in colonization of the lower airway by Pseudomonas species. Chest 1989, 95:155-161.
27. Gómez E., García Vázquez J., Gómez R. Clinical significance of bacterial resistance: a historical perspective 1982-2007. Rev Esp Quimioter 2008, 21:115-122.
28. Anton Y., Peleg C. Nosocomial infections caused by gram-negative bacteria. N Engl J Med 2010, 362:1804-1813.
29. Poirel L., Nordmann P. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin Microbiol Infect 2006, 12:826-836.
30. Alarcón T., López M., García P., Aznar A. Pattern of sensitivity of clinical isolates of Acinetobacter baumannii in Madrid vs. Hong Kong. Magazine Spanish Of Chemotherapy 2006, 16:45-50.
31. Vallésa J., Mariscalb D. Pneumonia due to Pseudomonas aeruginosa. Enferm Infecc Microbiol Clin 2005, 23:30-36.
32. Hart M., Espinosa F., Halley M., et al. Resistance to antibiotics in Acinetobacter baumannii isolated from January to March, 2010. Rev Cuba Med 2010, 49:218-227.
33. Anthony K., Fishman N., Linkin D., et al. Clinical and microbiological outcomes of serious infections with multidrug-resistant Gram-negative organisms treated with tigecicline. Clin Infect Dis 2008, 46:567-570.
34. Al Shirawi N., Memish Z., Cherfan A., Shimemeri A. Post-neurosurgical meningitis due to multidrug resistant Acinetobacter treated. J Chemother 2006, 12:225-230.